810211P

C12-NBD Ceramide

Avanti Research^™ - A Croda Brand 810211P, powder

• Synonim(y): N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine
• Wzór empiryczny (zapis Hilla): C₃₆H₆₁N₅O₆
• Numer CAS: 202850-01-9
• Masa cząsteczkowa: 659.90
• Kod UNSPSC: 12352211
• NACRES: NA.25

Właściwości

• Próba: >99% (TLC)
• Postać: powder
• opakowanie: pkg of 1 × 1 mg (810211P-1mg)
• producent / nazwa handlowa: Avanti Research^™ - A Croda Brand 810211P
• Warunki transportu: dry ice
• temp. przechowywania: −20°C
• InChI: 1S/C36H61N5O6/c1-2-3-4-5-6-7-8-9-10-12-15-18-21-24-33(43)31(29-42)38-34(44)25-22-19-16-13-11-14-17-20-23-28-37-30-26-27-32(41(45)46)36-35(30)39-47-40-36/h21,24,26-27,31,33,37,42-43H,2-20,22-23,25,28-29H2,1H3,(H,38,44)/b24-21+/t31-,33+/m0/s1
• Klucz InChI: SNOJCYCOPNIGIK-ULETYAGTSA-N

Opis

Opis ogólny

C12 7-nitro-2-1,3-benzoxadiazol-4-yl (NBD) ceramide is a long-chain fluorescent phospholipid. It is a natural analog of ceramide with C12 acyl chain length.

Zastosowanie

C12-NBD Ceramide or N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-erythro-sphingosine has been used as a substrate in ceramidase activity assay. It is also suitable for the lipid binding assays and in cell culture experiments for endothelial cells to determine the pro-apoptotic intracellular ceramide generation.

Działania biochem./fizjol.

C12-7-nitro-2-1,3-benzoxadiazol-4-yl (NBD) Ceramide is useful for measuring the alkaline and neutral ceramidase activity. It is involved in maintainingthe physical properties of ceramide required for cellular studies.

Opakowanie

5 mL Amber Glass Screw Cap Vial (810211P-1mg)

Informacje prawne

Avanti Research is a trademark of Avanti Polar Lipids, LLC

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 11 - Combustible Solids